+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drug Eluting Balloons Catheters Global Market Report 2024

  • PDF Icon

    Report

  • 175 Pages
  • March 2024
  • Region: Global
  • The Business Research Company
  • ID: 5948537
The drug eluting balloons catheters market size has grown rapidly in recent years. It will grow from $1.23 billion in 2023 to $1.43 billion in 2024 at a compound annual growth rate (CAGR) of 16.3%. The growth observed in the historical period can be attributed to factors such as the increasing prevalence of respiratory disorders, the advantages offered over traditional inhalers, patient preferences for dry powder inhalers (DPIs), government initiatives for respiratory health, strategic collaborations and partnerships in the healthcare sector, advancements in drug formulations, and the rising geriatric population.

The drug eluting balloons catheters market size is expected to see rapid growth in the next few years. It will grow to $2.35 billion in 2028 at a compound annual growth rate (CAGR) of 13.2%. The anticipated growth in the forecast period can be attributed to the ongoing increase in respiratory disorders, the expanding geriatric population, rising awareness and education regarding respiratory health, market expansion in emerging economies, the development of customized drug formulations, regulatory support and compliance, and innovations in packaging and design within the inhaler industry. Major trends expected in the forecast period include the emergence of smart inhalers and connectivity, a shift towards breath-actuated inhalers, a focus on meeting the needs of pediatric and geriatric patients, advancements in biologics delivery, and the development of environmentally friendly inhaler designs.

The anticipated rise in the prevalence of peripheral and cardiovascular diseases is set to drive the growth of the drug-eluting balloon catheter market in the future. Cardiovascular diseases (CVDs) encompass a range of conditions affecting the heart and circulatory system, while peripheral artery disease (PAD) specifically involves narrowed arteries reducing blood flow to the arms or legs. Drug-eluting balloon catheters, a treatment for coronary artery disease (CAD), employ a semi-compliant angioplasty balloon coated with an anti-proliferative substance, providing an anti-restenotic effect upon entering the vessel. For example, in April 2023, the British Heart Foundation reported a rise in coronary heart disease deaths in the UK from 64,170 in 2020 to 65,579 in 2021. Additionally, HMP Global projected that peripheral arterial disease prevalence in the US would reach 23.8 million by 2030, up from 21 million in 2020. Hence, the growing prevalence of peripheral and cardiovascular diseases is a driving force behind the drug-eluting balloon catheter market.

The increasing demand for minimally invasive procedures is expected to further propel the growth of the drug-eluting balloon catheter market. Minimally invasive procedures involve surgical techniques with small incisions, resulting in reduced healing time, less pain, and lower infection risks. Drug-eluting balloons are crucial in these procedures, delivering medication directly to the treatment area to prevent restenosis and enhance the effectiveness of vascular interventions. For instance, Intuitive Surgical Inc. reported an 18% increase in surgical procedures using Vinci surgical systems from 1,594,000 in 2021 to 1,875,000 in 2022. Additionally, the American Society of Plastic Surgeons noted a rise in cosmetic minimally invasive procedures in the US to 23,672,269 in 2022. Therefore, the increasing demand for minimally invasive procedures is driving the growth of the drug-eluting balloon catheter market.

The negative impact of adverse effects associated with the treatment hindered the growth of the drug-eluting balloon catheter market during the historic period. While drug-eluting balloons present a promising treatment for coronary artery disease, careful consideration is necessary due to potential side effects. Medtronic PLC highlighted potential complications, including balloon rupture, detachment of components, failure to perform as intended, and failure to cross the lesion during peripheral balloon catheterization. Hence, adverse effects can negatively impact the growth of the drug-eluting balloon catheter market.

Major companies in the drug-eluting balloon catheter market are intensifying their focus on developing next-generation products with advanced technologies to gain a competitive edge. For instance, Medtronic PLC launched Prevail DCB in Europe in July 2021, the latest-generation drug-coated balloon catheter for treating coronary artery disease. Integrating paclitaxel, a quickly absorbed drug, and PowerTrac technology from Medtronic Resolute Onyx DES delivery system, Prevail DCB offers superior deliverability and pushing power in PCI procedures.

In June 2023, Translumina Therapeutics Company acquired Blue Medical Devices BV for an undisclosed amount. This strategic acquisition aimed to integrate Blue Medical's unique drug application technology into Translumina's product lines, expanding offerings in neurovascular and peripheral interventions and enhancing drug coating capabilities. Blue Medical Devices BV is a Netherlands-based medical device company specializing in producing drug-eluting balloon catheters.

Major companies operating in the drug eluting balloons catheters market report are Abbott Laboratories, Medtronic PLC, Becton Dickinson and Company, Koninklijke Philips NV, Boston Scientific Corporation, B Braun Melsungen Aktiengesellschaft, Terumo Corporation, Cook Medical LLC, Lepu Medical Technology Co. Ltd., Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, BIOTRONIK SE & Co. KG, Acotec Scientific Co. Ltd., Cordis Corporation, Biosensors International Group Ltd., Zylox-Tonbridge Medical Technology Co. Ltd., Mermaid Medical AS, Hexacath Limited, Zhejiang Barty Medical Technology Co. Ltd., Cardionovum GmbH, Nano Therapeutics Pvt. Ltd., Tokai Medical Products Inc., Opto Circuits Limited, Acrostak (Schweiz) AG, Machine Solutions Inc., Concept Medical Inc., Aachen Resonance GmbH, AR Baltic Medical UAB.

North America was the largest region in the drug eluting balloons catheters market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug eluting balloons catheters market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the drug-eluting balloon catheter market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

A drug-eluting balloon catheter is a medical device utilized in the treatment of coronary artery disease through percutaneous coronary intervention (PCI). It is a semi-compliant angioplasty balloon that is coated with an anti-proliferative drug. During inflation, the drug is released into the vessel wall, aiming to prevent restenosis and reduce the risk of late thrombosis without the need for implanting a permanent foreign object.

The main types of drug-eluting balloon catheters include those designed for coronary artery disease and peripheral vascular disease. Coronary artery disease drug-eluting balloon catheters deliver antiproliferative drugs directly to the vessel wall using a lipophilic matrix, eliminating the need for a permanent structure such as a metal prosthesis or persistent polymer. Various drugs such as paclitaxel and sirolimus are used, and the catheters are made from raw materials such as nylon, polyurethane, and others. They find applications in hospitals, clinics, ambulatory surgical centers, and catheterization laboratories.

The drug eluting balloons catherers market research report is one of a series of new reports that provides drug eluting balloons catherers market statistics, including drug eluting balloons catherers industry global market size, regional shares, competitors with a drug eluting balloons catherers market share, detailed drug eluting balloons catherers market segments, market trends and opportunities, and any further data you may need to thrive in the drug eluting balloons catherers industry. This drug eluting balloons catherers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The drug-eluting balloon catheter market consists of sales of everolimus and stellarex. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.

Table of Contents

1. Executive Summary2. Drug Eluting Balloons Catheters Market Characteristics3. Drug Eluting Balloons Catheters Market Trends and Strategies
4. Drug Eluting Balloons Catheters Market - Macro Economic Scenario
4.1. Impact of High Inflation on the Market
4.2. Ukraine-Russia War Impact on the Market
4.3. COVID-19 Impact on the Market
5. Global Drug Eluting Balloons Catheters Market Size and Growth
5.1. Global Drug Eluting Balloons Catheters Market Drivers and Restraints
5.1.1. Drivers of the Market
5.1.2. Restraints of the Market
5.2. Global Drug Eluting Balloons Catheters Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Drug Eluting Balloons Catheters Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)
6. Drug Eluting Balloons Catheters Market Segmentation
6.1. Global Drug Eluting Balloons Catheters Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Coronary Artery Disease Drug-Eluting Balloon Catheters
  • Peripheral Vascular Disease Drug-Eluting Balloon Catheters
6.2. Global Drug Eluting Balloons Catheters Market, Segmentation by Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Paclitaxel
  • Sirolimus
  • Other Drugs
6.3. Global Drug Eluting Balloons Catheters Market, Segmentation by Raw Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Nylon
  • Polyurethane
  • Other Raw Materials
6.4. Global Drug Eluting Balloons Catheters Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Catheterization Laboratories
7. Drug Eluting Balloons Catheters Market Regional and Country Analysis
7.1. Global Drug Eluting Balloons Catheters Market, Split by Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Drug Eluting Balloons Catheters Market, Split by Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8. Asia-Pacific Drug Eluting Balloons Catheters Market
8.1. Asia-Pacific Drug Eluting Balloons Catheters Market Overview
(Region Information, Impact of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies)
8.2. Asia-Pacific Drug Eluting Balloons Catheters Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Drug Eluting Balloons Catheters Market, Segmentation by Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Drug Eluting Balloons Catheters Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
9. China Drug Eluting Balloons Catheters Market
9.1. China Drug Eluting Balloons Catheters Market Overview
9.2. China Drug Eluting Balloons Catheters Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Drug Eluting Balloons Catheters Market, Segmentation by Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Drug Eluting Balloons Catheters Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
10. India Drug Eluting Balloons Catheters Market
10.1. India Drug Eluting Balloons Catheters Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Drug Eluting Balloons Catheters Market, Segmentation by Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Drug Eluting Balloons Catheters Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11. Japan Drug Eluting Balloons Catheters Market
11.1. Japan Drug Eluting Balloons Catheters Market Overview
11.2. Japan Drug Eluting Balloons Catheters Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Drug Eluting Balloons Catheters Market, Segmentation by Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Drug Eluting Balloons Catheters Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12. Australia Drug Eluting Balloons Catheters Market
12.1. Australia Drug Eluting Balloons Catheters Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Drug Eluting Balloons Catheters Market, Segmentation by Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Drug Eluting Balloons Catheters Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13. Indonesia Drug Eluting Balloons Catheters Market
13.1. Indonesia Drug Eluting Balloons Catheters Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Drug Eluting Balloons Catheters Market, Segmentation by Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Drug Eluting Balloons Catheters Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14. South Korea Drug Eluting Balloons Catheters Market
14.1. South Korea Drug Eluting Balloons Catheters Market Overview
14.2. South Korea Drug Eluting Balloons Catheters Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Drug Eluting Balloons Catheters Market, Segmentation by Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Drug Eluting Balloons Catheters Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15. Western Europe Drug Eluting Balloons Catheters Market
15.1. Western Europe Drug Eluting Balloons Catheters Market Overview
15.2. Western Europe Drug Eluting Balloons Catheters Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Drug Eluting Balloons Catheters Market, Segmentation by Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Drug Eluting Balloons Catheters Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16. UK Drug Eluting Balloons Catheters Market
16.1. UK Drug Eluting Balloons Catheters Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Drug Eluting Balloons Catheters Market, Segmentation by Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Drug Eluting Balloons Catheters Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17. Germany Drug Eluting Balloons Catheters Market
17.1. Germany Drug Eluting Balloons Catheters Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Drug Eluting Balloons Catheters Market, Segmentation by Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Drug Eluting Balloons Catheters Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18. France Drug Eluting Balloons Catheters Market
18.1. France Drug Eluting Balloons Catheters Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Drug Eluting Balloons Catheters Market, Segmentation by Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Drug Eluting Balloons Catheters Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19. Italy Drug Eluting Balloons Catheters Market
19.1. Italy Drug Eluting Balloons Catheters Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Drug Eluting Balloons Catheters Market, Segmentation by Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Drug Eluting Balloons Catheters Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20. Spain Drug Eluting Balloons Catheters Market
20.1. Spain Drug Eluting Balloons Catheters Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Drug Eluting Balloons Catheters Market, Segmentation by Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Drug Eluting Balloons Catheters Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21. Eastern Europe Drug Eluting Balloons Catheters Market
21.1. Eastern Europe Drug Eluting Balloons Catheters Market Overview
21.2. Eastern Europe Drug Eluting Balloons Catheters Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Drug Eluting Balloons Catheters Market, Segmentation by Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Drug Eluting Balloons Catheters Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22. Russia Drug Eluting Balloons Catheters Market
22.1. Russia Drug Eluting Balloons Catheters Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Drug Eluting Balloons Catheters Market, Segmentation by Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Drug Eluting Balloons Catheters Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23. North America Drug Eluting Balloons Catheters Market
23.1. North America Drug Eluting Balloons Catheters Market Overview
23.2. North America Drug Eluting Balloons Catheters Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Drug Eluting Balloons Catheters Market, Segmentation by Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Drug Eluting Balloons Catheters Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24. USA Drug Eluting Balloons Catheters Market
24.1. USA Drug Eluting Balloons Catheters Market Overview
24.2. USA Drug Eluting Balloons Catheters Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Drug Eluting Balloons Catheters Market, Segmentation by Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Drug Eluting Balloons Catheters Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25. Canada Drug Eluting Balloons Catheters Market
25.1. Canada Drug Eluting Balloons Catheters Market Overview
25.2. Canada Drug Eluting Balloons Catheters Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Drug Eluting Balloons Catheters Market, Segmentation by Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Drug Eluting Balloons Catheters Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26. South America Drug Eluting Balloons Catheters Market
26.1. South America Drug Eluting Balloons Catheters Market Overview
26.2. South America Drug Eluting Balloons Catheters Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Drug Eluting Balloons Catheters Market, Segmentation by Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Drug Eluting Balloons Catheters Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27. Brazil Drug Eluting Balloons Catheters Market
27.1. Brazil Drug Eluting Balloons Catheters Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Drug Eluting Balloons Catheters Market, Segmentation by Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Drug Eluting Balloons Catheters Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28. Middle East Drug Eluting Balloons Catheters Market
28.1. Middle East Drug Eluting Balloons Catheters Market Overview
28.2. Middle East Drug Eluting Balloons Catheters Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Drug Eluting Balloons Catheters Market, Segmentation by Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Drug Eluting Balloons Catheters Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29. Africa Drug Eluting Balloons Catheters Market
29.1. Africa Drug Eluting Balloons Catheters Market Overview
29.2. Africa Drug Eluting Balloons Catheters Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Drug Eluting Balloons Catheters Market, Segmentation by Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Drug Eluting Balloons Catheters Market, Segmentation by End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
30. Drug Eluting Balloons Catheters Market Competitive Landscape and Company Profiles
30.1. Drug Eluting Balloons Catheters Market Competitive Landscape
30.2. Drug Eluting Balloons Catheters Market Company Profiles
30.2.1. Abbott Laboratories
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. Medtronic PLC
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. Becton Dickinson and Company
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. Koninklijke Philips NV
30.2.4.1. Overview
30.2.4.2. Products and Services
30.2.4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. Boston Scientific Corporation
30.2.5.1. Overview
30.2.5.2. Products and Services
30.2.5.3. Strategy
30.2.5.4. Financial Performance
31. Drug Eluting Balloons Catheters Market Other Major and Innovative Companies
31.1. B Braun Melsungen Aktiengesellschaft
31.2. Terumo Corporation
31.3. Cook Medical LLC
31.4. Lepu Medical Technology Co. Ltd.
31.5. Meril Life Sciences Pvt. Ltd.
31.6. MicroPort Scientific Corporation
31.7. BIOTRONIK SE & Co. KG
31.8. Acotec Scientific Co. Ltd.
31.9. Cordis Corporation
31.10. Biosensors International Group Ltd.
31.11. Zylox-Tonbridge Medical Technology Co. Ltd.
31.12. Mermaid Medical AS
31.13. Hexacath Limited
31.14. Zhejiang Barty Medical Technology Co. Ltd.
31.15. Cardionovum GmbH
32. Global Drug Eluting Balloons Catheters Market Competitive Benchmarking33. Global Drug Eluting Balloons Catheters Market Competitive Dashboard34. Key Mergers and Acquisitions in the Drug Eluting Balloons Catheters Market
35. Drug Eluting Balloons Catheters Market Future Outlook and Potential Analysis
35.1 Drug Eluting Balloons Catheters Market in 2028 - Countries Offering Most New Opportunities
35.2 Drug Eluting Balloons Catheters Market in 2028 - Segments Offering Most New Opportunities
35.3 Drug Eluting Balloons Catheters Market in 2028 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic and Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Analyst
36.6. Copyright and Disclaimer

Executive Summary

Drug Eluting Balloons Catheters Global Market Report 2024 provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on drug eluting balloons catheters market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Description:

Where is the largest and fastest growing market for drug eluting balloons catheters ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The drug eluting balloons catheters market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
  • The impact of higher inflation in many countries and the resulting spike in interest rates.
  • The continued but declining impact of COVID-19 on supply chains and consumption patterns.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

1) By Product: Coronary Artery Disease Drug-Eluting Balloon Catheters; Peripheral Vascular Disease Drug-Eluting Balloon Catheters.
2) By Drug: Paclitaxel; Sirolimus; Other Drugs
3) By Raw Material: Nylon; Polyurethane; Other Raw Materials
4) By End-User: Hospitals And Clinics; Ambulatory Surgical Centers; Catheterization Laboratories

Key Companies Mentioned: Abbott Laboratories; Medtronic PLC; Becton Dickinson and Company; Koninklijke Philips NV; Boston Scientific Corporation

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.

Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Companies Mentioned

  • Abbott Laboratories
  • Medtronic PLC
  • Becton Dickinson and Company
  • Koninklijke Philips NV
  • Boston Scientific Corporation
  • B Braun Melsungen Aktiengesellschaft
  • Terumo Corporation
  • Cook Medical LLC
  • Lepu Medical Technology Co. Ltd.
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation
  • BIOTRONIK SE & Co. KG
  • Acotec Scientific Co. Ltd.
  • Cordis Corporation
  • Biosensors International Group Ltd.
  • Zylox-Tonbridge Medical Technology Co. Ltd.
  • Mermaid Medical AS
  • Hexacath Limited
  • Zhejiang Barty Medical Technology Co. Ltd.
  • Cardionovum GmbH
  • Nano Therapeutics Pvt. Ltd.
  • Tokai Medical Products Inc.
  • Opto Circuits Limited
  • Acrostak (Schweiz) AG
  • Machine Solutions Inc.
  • Concept Medical Inc.
  • Aachen Resonance GmbH
  • AR Baltic Medical UAB

Methodology

Loading
LOADING...

Table Information